1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 8th April 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

SARS-CoV-2 infection and persistence in the human body and brain at autopsy, 2022, Stein et al

Discussion in 'Long Covid research' started by Andy, Dec 22, 2021.

  1. Andy

    Andy Committee Member

    Messages:
    21,906
    Location:
    Hampshire, UK
    Preprint

    Abstract

    COVID-19 is known to cause multi-organ dysfunction1-3 in acute infection, with prolonged symptoms experienced by some patients, termed Post-Acute Sequelae of SARS-CoV-2 (PASC)4-5. However, the burden of infection outside the respiratory tract and time to viral clearance is not well characterized, particularly in the brain3,6-14. We performed complete autopsies on 44 patients with COVID-19 to map and quantify SARS-CoV-2 distribution, replication, and cell-type specificity across the human body, including brain, from acute infection through over seven months following symptom onset. We show that SARS-CoV-2 is widely distributed, even among patients who died with asymptomatic to mild COVID-19, and that virus replication is present in multiple extrapulmonary tissues early in infection. Further, we detected SARS-CoV-2 RNA in multiple anatomic sites, including regions throughout the brain, for up to 230 days following symptom onset. Despite extensive distribution of SARS-CoV-2 in the body, we observed a paucity of inflammation or direct viral cytopathology outside of the lungs. Our data prove that SARS-CoV-2 causes systemic infection and can persist in the body for months.

    Open access, https://www.researchsquare.com/article/rs-1139035/v1
     
    Last edited by a moderator: Aug 5, 2023
    Simon M, Hutan, Wyva and 7 others like this.
  2. rvallee

    rvallee Senior Member (Voting Rights)

    Messages:
    12,413
    Location:
    Canada
    If anyone is able to read through this, did they specifically look for SARS-CoV-2? Or would their methods also find other viruses or pathogens? With so many infections that are known to infect most humans, it's hard to think this would be the only one to do this.
     
  3. hibiscuswahine

    hibiscuswahine Senior Member (Voting Rights)

    Messages:
    464
    They used ISH to detect SARS-CoV-2 in the brain tissue. Technique described here in this article https://www.ncbi.nlm.nih.gov/probe/docs/techish/
    It is used for many different situations.
    https://www.sciencedirect.com/topic...s-and-molecular-biology/in-situ-hybridization

    including EBV associated lymphomas
    https://academic.oup.com/jid/article/200/7/1078/905519
     
    Simon M, Hutan, merylg and 4 others like this.
  4. zzz

    zzz Senior Member (Voting Rights)

    Messages:
    214
    Location:
    Oregon
    Last edited by a moderator: Dec 28, 2021
    Simon M, Hutan, nick2155 and 8 others like this.
  5. Three Chord Monty

    Three Chord Monty Senior Member (Voting Rights)

    Messages:
    208
    A few interesting Twitter threads on this:

    https://twitter.com/user/status/1473721448342687754


    Amy Proal also quote-tweeted that in a thread where she brings up possible relevance to ME/CFS, which I'll link in the larger "ME/CFS following Covid" thread.

    Zoe Hyde (who has 65,000 followers as compared to Amy Proal's approx 12,000) also tweeted about it here

    https://twitter.com/user/status/1475722062719111172


    which inspired a more critical thread that I include here because, in spite of the importance of the implications raised by this preprint, contains interesting points about the importance of presenting scientific information to the lay public in context:

    https://twitter.com/user/status/1476209804666601472
     
    ME/CFS Skeptic, obeat and Wyva like this.
  6. Joan Crawford

    Joan Crawford Senior Member (Voting Rights)

    Messages:
    564
    Location:
    Warton, Carnforth, Lancs, UK
    Merged thread

    Published in Nature today

    https://www.nature.com/articles/s41586-022-05542-y

    Abstract

    Coronavirus disease 2019 (COVID-19) is known to cause multi-organ dysfunction1,2,3 during acute infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with some patients experiencing prolonged symptoms, termed post-acute sequelae of SARS-CoV-2 (refs. 4,5). However, the burden of infection outside the respiratory tract and time to viral clearance are not well characterized, particularly in the brain3,6,7,8,9,10,11,12,13,14. Here we carried out complete autopsies on 44 patients who died with COVID-19, with extensive sampling of the central nervous system in 11 of these patients, to map and quantify the distribution, replication and cell-type specificity of SARS-CoV-2 across the human body, including the brain, from acute infection to more than seven months following symptom onset.

    We show that SARS-CoV-2 is widely distributed, predominantly among patients who died with severe COVID-19, and that virus replication is present in multiple respiratory and non-respiratory tissues, including the brain, early in infection. Further, we detected persistent SARS-CoV-2 RNA in multiple anatomic sites, including throughout the brain, as late as 230 days following symptom onset in one case. Despite extensive distribution of SARS-CoV-2 RNA throughout the body, we observed little evidence of inflammation or direct viral cytopathology outside the respiratory tract. Our data indicate that in some patients SARS-CoV-2 can cause systemic infection and persist in the body for months.
     
    Last edited by a moderator: Aug 5, 2023
    sebaaa, John Mac, Ebb Tide and 8 others like this.
  7. Hutan

    Hutan Moderator Staff Member

    Messages:
    26,839
    Location:
    Aotearoa New Zealand
    Patient 42 died at 230 days after onset of symptoms, had only mild or no respiratory symptoms, and died with, not from, COVID-19. Viral RNA was found in this patient's spinal cord and basal ganglia. A young person, who probably died due to a pre-existing seizure disorder, didn't show an inflammatory response. There wasn't much evidence of infection in the brains with virus present - they note vascular congestion was observed.

    I assume the following means that they found virus in different parts of people's bodies, with some genetic variation in different parts of the body (but presumably still close enough that it's unlikely that this was due to multiple infections). They seem to be suggesting that the rate of mutation was less than they might have expected. I wonder if the virus just holes up in some tissues, not replicating much, and so not mutating much.
     
  8. CRG

    CRG Senior Member (Voting Rights)

    Messages:
    1,857
    Location:
    UK
    Characteristics of the study population - 52.3% obesese, 61.4% with 3 or more comorbidities, 61.4% with hypertension, 68.2% over the age of 55 - whatever this study tells us about SARS COVID 19, it has only limited application to how the virus impacts younger/healthier populations.

    [​IMG]
     
    Joan Crawford and Peter Trewhitt like this.
  9. John Mac

    John Mac Senior Member (Voting Rights)

    Messages:
    921
  10. SNT Gatchaman

    SNT Gatchaman Senior Member (Voting Rights)

    Messages:
    4,403
    Location:
    Aotearoa New Zealand
  11. Midnattsol

    Midnattsol Moderator Staff Member

    Messages:
    3,592
    Seeing that obesity and non-communicable diseases are common globally, also increasingly in the young, we need studies that look at this population. It encompasses a lot of people.
     
    obeat likes this.

Share This Page